![](/img/cover-not-exists.png)
Combined TXA2 synthase inhibitor/PGH1 receptor antagonism (ridogrel) needs heparin but reduces the RT-PA requirement for effective coronary thrombolysis
A. Van de Water, R. Xhonneux, J.T. Willerson, F. De ClerckVolume:
65
Year:
1992
Language:
english
DOI:
10.1016/0049-3848(92)90712-j
File:
PDF, 64 KB
english, 1992